share_log

12 Health Care Stocks Moving In Thursday's After-Market Session

Benzinga ·  May 31 04:31

Gainers

  • MyMD Pharmaceuticals (NASDAQ:MYMD) stock rose 46.0% to $2.89 during Thursday's after-market session. The market value of their outstanding shares is at $6.6 million.
  • Adaptimmune Therapeutics (NASDAQ:ADAP) stock moved upwards by 31.68% to $1.33. The market value of their outstanding shares is at $339.8 million.
  • China Pharma Holdings, Inc. Common Stock (AMEX:CPHI) shares moved upwards by 12.83% to $0.33.
  • BiomX (AMEX:PHGE) stock rose 6.24% to $0.44. The market value of their outstanding shares is at $31.0 million.
  • Virios Therapeutics (NASDAQ:VIRI) stock increased by 6.12% to $0.22. The market value of their outstanding shares is at $6.1 million.
  • Accuray (NASDAQ:ARAY) stock increased by 5.73% to $1.66. The company's market cap stands at $164.7 million.

Losers

  • Veeva Systems (NYSE:VEEV) stock fell 7.8% to $179.0 during Thursday's after-market session. The company's market cap stands at $28.9 billion. The company's, Q1 earnings came out today.
  • Intelligent Bio Solutions (NASDAQ:INBS) shares fell 6.64% to $2.23. The company's market cap stands at $6.9 million.
  • Reshape Lifesciences (NASDAQ:RSLS) stock decreased by 6.6% to $0.23. The market value of their outstanding shares is at $5.4 million.
  • OneMedNet (NASDAQ:ONMD) stock decreased by 6.14% to $2.45. The company's market cap stands at $58.4 million.
  • Cosmos Health (NASDAQ:COSM) stock fell 5.0% to $0.66. The market value of their outstanding shares is at $11.0 million.
  • Abeona Therapeutics (NASDAQ:ABEO) stock fell 4.99% to $4.0. The company's market cap stands at $164.7 million.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment